These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 12665900)
1. [Construction of recombinant vaccinia virus co-expressing mutant E6 plus E7 proteins and detection of its immunogenicity and antitumor response]. Zhi H; Han L; Ren J; Tian H; Luo W; Liang Y; Ruan L Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):341-4. PubMed ID: 12665900 [TBL] [Abstract][Full Text] [Related]
2. [Modification of HPV type 16 E6 and E7 genes, and analysis of stability and immunogenicity of the modified proteins]. Zhi H; Han L; Ren J; Tian H; Luo W; Liang Y; Ruan L Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):124-7. PubMed ID: 12196821 [TBL] [Abstract][Full Text] [Related]
3. [Non-replicating recombinant vaccinia virus expressing HPV16 E6 and E7 proteins elicits anti-tumor immunity in mice]. Luo WF; Han LQ; Ren J; Tian HW; Lu ZH; Zhao L; Gu SY; Ruan L Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):335-9. PubMed ID: 12921560 [TBL] [Abstract][Full Text] [Related]
4. [Construction of recombinant vaccinia virus expressing HPV18E7E6 fusion proteins and detection of its immunogenicity in mice]. Zhao L; Ren J; Feng J; Gao J; Zhang H; Tian HW; Ruan L Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):189-91. PubMed ID: 19031699 [TBL] [Abstract][Full Text] [Related]
5. A DNA vaccine constructed with human papillomavirus type 16 (HPV16) E7 and E6 genes induced specific immune responses. Yan Q; Cheung YK; Cheng SC; Wang XH; Shi M; Hu MH; Yong X Gynecol Oncol; 2007 Jan; 104(1):199-206. PubMed ID: 17049969 [TBL] [Abstract][Full Text] [Related]
6. [Experimental study of the immuno-protective activity of recombinant vaccinia virus expressing HPV58 E7]. Luo LQ; Li J; Liu X; Zhang YH Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Feb; 25(1):43-6. PubMed ID: 12905606 [TBL] [Abstract][Full Text] [Related]
7. [Expression of the human papillomavirus type 16L/E7 fusion protein in E. coli and observation of its immunogenicity in mice]. Tian HW; Ye ZM; Lu ZH; Jao R; Bian T; Zhao L; Ruan L Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):33-7. PubMed ID: 16816859 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin. Hsieh CJ; Kim TW; Hung CF; Juang J; Moniz M; Boyd DA; He L; Chen PJ; Chen CH; Wu TC Vaccine; 2004 Sep; 22(29-30):3993-4001. PubMed ID: 15364449 [TBL] [Abstract][Full Text] [Related]
9. [Construction and identification of non-replication recombinant vaccinia virus co-expressing human papillomavirus type 16 L1/L2/E6/E7 proteins]. Huang W; Tian HW; Ren J; Fan JT; Zhao L; Bian T; Lu ZH; Ruan L Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):240-3. PubMed ID: 16261206 [TBL] [Abstract][Full Text] [Related]
10. DNA vaccine encoding heat shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens. Huang CY; Chen CA; Lee CN; Chang MC; Su YN; Lin YC; Hsieh CY; Cheng WF Gynecol Oncol; 2007 Dec; 107(3):404-12. PubMed ID: 17905417 [TBL] [Abstract][Full Text] [Related]
11. [The recombinant vaccinia viruses expressing HPV type 16 wild or mutant E7 protein elicit immunity against tumor cells in mice]. Zhi H; Han L; Ren J; Tian HW; Lao WF; Liang Y; Ruan L Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):222-5. PubMed ID: 11986689 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant effect of dendritic cells transduced with recombinant vaccinia virus expressing HPV16-E7 is inhibited by co-expression of IL12. Mackova J; Kutinova L; Hainz P; Krystofova J; Sroller V; Otahal P; Gabriel P; Nemeckova S Int J Oncol; 2004 Jun; 24(6):1581-8. PubMed ID: 15138603 [TBL] [Abstract][Full Text] [Related]
13. Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect. Pokorná D; Macková J; Dusková M; Rittich S; Ludvíková V; Smahel M J Gene Med; 2005 Jun; 7(6):696-707. PubMed ID: 15712328 [TBL] [Abstract][Full Text] [Related]
14. [Construction of recombinant vaccina virus of HPV16 and its antitumor effect]. Huang W; Tian HW; Ren J; Fan JT; Zhao L; Ruan L Ai Zheng; 2005 Jul; 24(7):817-22. PubMed ID: 16004807 [TBL] [Abstract][Full Text] [Related]
15. Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection. Cheung YK; Cheng SC; Sin FW; Xie Y Vaccine; 2004 Dec; 23(5):629-38. PubMed ID: 15542183 [TBL] [Abstract][Full Text] [Related]
17. Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia. Baldwin PJ; van der Burg SH; Boswell CM; Offringa R; Hickling JK; Dobson J; Roberts JS; Latimer JA; Moseley RP; Coleman N; Stanley MA; Sterling JC Clin Cancer Res; 2003 Nov; 9(14):5205-13. PubMed ID: 14614000 [TBL] [Abstract][Full Text] [Related]
18. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502 [TBL] [Abstract][Full Text] [Related]
19. Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization. Daemen T; Riezebos-Brilman A; Regts J; Dontje B; van der Zee A; Wilschut J Antivir Ther; 2004 Oct; 9(5):733-42. PubMed ID: 15535411 [TBL] [Abstract][Full Text] [Related]
20. Development of an adenoviral vaccine against E6 and E7 oncoproteins to prevent growth of human papillomavirus-positive cancer. Lee DW; Anderson ME; Wu S; Lee JH Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1316-23. PubMed ID: 19075129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]